Candel Therapeutics Inc（纳斯达克：CADL）宣布其公开募股定价细节。该公司将以每股5.45美元的价格发行18,348,624股普通股。此次募股预计将为这家临床阶段生物技术公司注入新的资金流。
定价决策基于当前市场条件与投资者需求。每股5.45美元的定价反映了资本市场对Candel Therapeutics研发管线的估值预期。此次发行规模与定价的组合，将直接影响公司市值与股权结构。
（注：文中时间信息存在逻辑矛盾，原始数据提及2026年2月20日的时间戳与事件发布日不匹配，故对时间表述进行技术性处理。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.